Sasha Stafford Professional Experience
Sasha is a senior translational scientist and consultant dedicated to moving medical breakthroughs from the lab to patients. He specializes in biomaterials and drug delivery.
Wyss Institute at Harvard
Leading efforts to translate complex drug delivery technologies into clinical use. He manages high-level collaborations between academic researchers and major industry partners.
PRESENT ROLE
Consultant & Researcher
A proven leader in CMC and QMS, Sasha ensures technologies meet ICH and FDA standards. He mentors teams to bridge the gap between scientific discovery and regulated production.
KEY EXPERTISE
Healthcare Expert
Expertise in building therapeutic systems that satisfy global regulatory bodies. He works with biotech and pharma leaders to create scalable solutions that improve patient compliance and reduce suffering.
CORE CAREER
Alexander (Sasha) Stafford is a senior translational scientist at the Wyss Institute at Harvard University, where he leads biomaterials and drug‑delivery programs at the interface of academia and industry. Trained in chemistry, bioengineering, and finance, he works on hydrogel- and scaffold‑based platforms for vaccines, oncology, and regenerative medicine.
Over more than a decade at Wyss and earlier roles in pharma and biotech, Sasha has taken multiple technologies from early research toward clinical and commercial application. He is an inventor on foundational patents, has helped secure multi‑million‑dollar sponsored research agreements, and has contributed to first‑in‑human studies and IND‑enabling CMC packages.
Sasha brings deep experience in analytical development, quality, and regulatory expectations, including method qualification, ICH/FDA guidance, and quality management systems. He has run cGMP‑aligned laboratories, overseen contract manufacturing and testing, and supported regulatory submissions and audits.
As a manager and collaborator, Sasha has led scientists and research associates, mentored students and postdocs, and partnered closely with academic labs, biotech and pharma teams, and cross‑functional consortia. His focus is on building robust, scalable platforms that translate complex biomaterials into practical clinical solutions.
Core Competencies
Drug Delivery & Biomaterials: Hydrogels & Cryogels
LNPs & Liposomes
PLGA Microparticles
Controlled Release
Analytical & Quality: HPLC & ELISA Methods
cGMP Compliance
Data Validation
Regulatory & Translational: IND Filing Support
Clinical Bridge Strategy
Leadership & Collaboration: Technical Advisory
Stakeholder Management
Project Oversight
Skills and Expertise
Drug Delivery & Biomaterials
Hydrogels and cryogels; click‑crosslinked alginates; injectable scaffolds; lipid nanoparticles (LNPs); liposomes and micelles; virosomes; PLGA microparticles and scaffolds; mRNA and nucleic‑acid delivery; vaccine depots and combination products.
Analytical & Quality
HPLC (reverse‑phase, SEC, GPC, IEC, HILIC, chiral), ELISA, capillary electrophoresis, PAGE and Western blot, IEF, FTIR, rheology, dynamic light scattering, microscopy, flow cytometry, spectroscopic assays, dissolution and stability testing, clinical kit and final product configuration. cGMP laboratory operations, assay development and remediation, method qualification and validation, QC release and stability programs.
Regulatory & Translational
ICH/FDA‑aligned method qualification (e.g., ICH Q2(R1)), CMC support for IND submissions, quality management systems, SOP and documentation systems, audit preparation and defense, tech transfer to industry, oversight of CMOs and CROs, safety and compliance programs.
Leadership & Collaboration
Team leadership and mentoring of scientists, research associates, and students; cross‑functional project management; interface with clinical, QA, and development teams; industry‑academic partnerships; sponsored research agreements; presentations at scientific meetings and consortia.